Fate Therapeutics Inc (FATE)

[Spideyboy]

To JRMKE:

We see again that I was correct that the expenses have increased again, now to 29.5 million in this last quarter. This will again go up with initiation of FT596 for phase I trial. Their quarterly expenses have gone up by almost 10 million per quarter since just over a year ago, and still 7 years away from any potential product approval.

I hadn't even seen the massive 190 million additional injection that they raised in September. Much earlier than even I had expected.

With 303 million in cash, that's good to go another 2.5 years. But at the current rate they are seeking injections maybe about 1.5 - 2 years tops before another massive dilution.

Still wondering how your cash expense calculations are going?